ReviewArtificial DNA, PNA & XNA
Artificial DNA and surface plasmon resonance.
Review in Artificial DNA, PNA & XNA. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Applications of Surface Plasmon Resonance for Advanced Studies Involving Nucleic Acids.RNA nanomed · 2024Article
- A review on plasmonic and metamaterial based biosensing platforms for virus detection.Sensing and Bio-Sensing Research · 2021Review
- Development of Diagnostic Tests Provides Technical Support for the Control of African Swine Fever.Vaccines · 2021Review
- Surface Plasmon Resonance for Biomarker Detection: Advances in Non-invasive Cancer Diagnosis.Frontiers in chemistry · 2019Review
- Peptide Nucleic Acid-Based Biosensors for Cancer Diagnosis.Molecules (Basel, Switzerland) · 2017Review
- Surface plasmon resonance: a versatile technique for biosensor applications.Sensors (Basel, Switzerland) · 2015Review
- Surface plasmon resonance applications in clinical analysis.Analytical and bioanalytical chemistry · 2014Review
- Miravirsen (SPC3649) can inhibit the biogenesis of miR-122.Nucleic acids research · 2014Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The combined use of surface plasmon resonance (SPR) and modified or mimic oligonucleotides have expanded diagnostic capabilities of SPR-based biosensors and have allowed detailed studies of molecular recognition processes. This review summarizes the most significant advances made in this area over the past 15 years. Functional and conformationally restricted DNA analogs (e.g., aptamers and PNAs) when used as components of SPR biosensors contribute to enhance the biosensor sensitivity and selectivity. At the same time, the SPR technology brings advantages that allows forbetter exploration of underlying properties of non-natural nucleic acid structures such us DNAzymes, LNA and HNA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.